Posted in M&A / Deals AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid April 13, 2026 Pharmaceutical Technology AbbVie’s deal with Haisco comes as many pharma companies look to restock their pipelines amid looming global patent expiries. M&A / DealsPain & AnaesthesiaRead full story